BioNTech (BNTX)
(Delayed Data from NSDQ)
$87.95 USD
+0.74 (0.85%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $87.92 -0.03 (-0.03%) 7:28 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Brokerage Reports
0 items in cart
BioNTech SE Sponsored ADR [BNTX]
Reports for Purchase
Showing records 81 - 100 ( 152 total )
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT211 Shows Encouraging ORR in Solid Tumors; New Collaboration Inked; Modulating PT to $298
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
MediGene Oncology TCR-Based Collaboration Inked; Modulating PT to $339
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
FDA Delays Advisory Committee on COMIRNATY in Young Kids; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Multiple COVID-19 Vaccine Updates; Attrition Unwarranted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BNTX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Fourth Booster Dose Appears to Provide Little Protection; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COMIRNATY Booster Emergency Use Authorization Expanded; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COMIRNATY E.U. Supply Increase; Omicron Data Update; Modulating PT to $366
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Novel Variant Emerges; COMIRNATY Updates; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Broadened COMIRNATY Booster Approval Likely; Upgrading to Buy and $360 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Projected COMIRNATY Sales Set to Break Records; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
CHMP Recommends Booster Shots; Oncology Pipeline Updates; Reit Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Potential COMIRNATY FDA Approval for Children Expected in 4Q21; Reit Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R